5Zaniboni A, Meriqqi F. The emerging role of oxaliplatin in thetreatment of gastric ancer[J]. J Chemothe, 2005, 17(6) :656.
6Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapyfor gastric cancer with S-l, an oral fluoropyrimidine[J]. N Engl JMed, 2007, 357(18):1810-1820.
4Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer ( SPI- RITS trial) : a phase Ⅲ trial[J]. Lancet Oncol,2008, 9(3) : 215 -221.
5Chollet P, Schoffski P, Weigang-Kohler K, et al. Phase Ⅱ trial with S-1 in chemotherapy-naive patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group ( EC- SG) [J]. Eur J Cancer, 2003, 39(9) : 1264 - 1270.
6Park YH, Lee JL, Ryoo BY, et al. Capecitabine in combination with oxaliplatin ( XELOX ) as a first-line therapy for advanced gastric cancer [ J ]. Cancer Chemother Pharmacol, 2008, 61 (4) : 623 - 629.
7Koizumi W, Takiuchi H, Yamada Y,et al. Phase Ⅱ study of ox- aliplatin plus S-1 as first-line treatment for advanced gastric canc- er ( G-SOX study) [ J ]. Ann Oncol, 2010, 21 ( 5 ) : 1001 - 1005.
8American Cancer Society. Global Cancer Facts & Figures [M] . ,d 2011. 2 Edmon. Atlanta: American Cancer Society,.
9PYRHONEN S, KUITUNEN T, NYANDOTO P, et al. Randomised comparison of fluorouracil, epirubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer [ J ] . Br J Cancer, 1995, 71(3): 587-591.
10GLIMELIUS B, EKSTROM K, HOFFMAN K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer [ J ] . Ann Oncol, 1997, 8(2): 163-168.
